# LIROH - Liraglutide for Obesity in HIV

> **NCT06438146** · PHASE4 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Obesity
- HIV Infections

## Interventions

- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT06438146
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-02
- **Primary completion:** 2025-05
- **Final completion:** 2025-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06438146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06438146, "LIROH - Liraglutide for Obesity in HIV". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06438146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*